$EXEL 3 SEC Filings

Filed On	Filing
20 Nov 2025	Form 3: Hefti Brenda, SVP and General Counsel Holds 90,441 shares of Common Stock
09 Jan 2024	Form 3: Eckhardt Sue Gail, Director No securities owned
09 Jan 2024	Form 3: Beckerle Mary C, Director No securities owned
25 Aug 2023	Form 3: Peterson Amy C., EVP Prod Dev & Med Aff & CMO No securities owned
02 Jun 2023	Form 3: Heyman Tomas J., Director No securities owned
02 Jun 2023	Form 3: Oliver Bob, Director No securities owned
02 Jun 2023	Form 3: Johnson David Edward, Director and 1 other Holds 910,730 shares of Common Stock, par value $0.001 per share
23 Dec 2022	Form 3: Aftab Dana, CSO/EVP Disc & Trans Research Holds 253,001 shares of Common Stock
06 Jan 2022	Form 3: Goodman Vicki L, EVP, Prod Dev & Med Aff &CMO No securities owned
17 Dec 2021	Form 3: Wright Jacqueline, Director No securities owned
09 Apr 2018	Form 3: Freire Maria C, Director No securities owned
21 Dec 2016	Form 3: Haley Patrick J., Sr. Vice President, Commercial Holds 109,693 shares of Common Stock
26 Sep 2016	Form 3: Smith Julie, Director No securities owned
17 Jul 2015	Form 3: Senner Christopher J., EVP and CFO No securities owned
06 Jun 2014	Form 3: Burke Deborah, VP & Interim CFO Holds 14,136 shares of Common Stock
12 Feb 2014	Form 3: Hessekiel Jeffrey, EVP and General Counsel No securities owned
24 Oct 2011	Form 3: Garland J. Scott, EVP & Chief Commerical Officer No securities owned
05 Aug 2008	Form 3: Heller Frances K, EVP, Business Development Holds 1,500 shares of Common Stock
09 Feb 2007	Form 3: Feldbaum Carl B, Director No securities owned
23 Jan 2007	Form 3: Lamb Peter, SVP, Discovery Research & CSO Holds 2,680 shares of Common Stock

Comments